AACR Annual Meeting 2017


Vectalys will attend the AACR Annual Meeting in Washington DC, April 1-5, 2017‎.

The AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world.
Last year our team has introduced a new non-integrative lentiviral particle, LentiFlashTM. This year we look forward to sharing gene editing and immunotherapy applications of LentiFlashTM with you.

If you are attending the AACR 2017, come and meet us at booth #2060 in the exhibit hall, we will be delighted to talk about your projects, to answer your questions and to share scientific data about our lentiviral tools.

Additionally, Régis Gayon (vectorology and cell models manager) and Christine Duthoit (in vivo models manager) will present two posters:

  • Poster 1 (Tuesday April 4, 1pm to 5pm. Halls A-C, poster section 25, board #6)

Non-integrative lentiviral particles for immunotherapy: RNA delivery to drive tumoral antigen presentation in a safe and efficient way

Session category: Clinical immunotherapy, viruses and bacteria

  • Poster 2 (Wednesday April 5, 8am to 12pm. Halls A-C, poster section 3, board #6)

Efficient KO of PD1 into primary T cells using a new non-integrative lentiviral particle expressing CRISPR/Cas9 system

Session category: Gene and vector based therapy

To schedule a meeting with us or to ask a question before coming, please click here.